[Diacetyl-glucaro-(1 leads to 4) (6 leads to 3)-dilactone (SLA) for prevention of bladder tumor recurrence].
D000085:Acetates / Q000627:therapeutic use; D000272:Adipates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D005966:Glucuronidase / Q000037:antagonists & inhibitors*; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery
D000085:Acetates; D000272:Adipates; D007783:Lactones; D005966:Glucuronidase